Metabolic Surgery for Non-Obese Type 2 Diabetes

The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action

(2010) K. J. Hare et al.   DIABETES

Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice

(2009) Ryuichi Moriya et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Evaluation of proposed oral disposition index measures in relation to the actual disposition index

(2009) R. Retnakaran et al.   DIABETIC MEDICINE

Surgery for Nonobese Type 2 Diabetic Patients: An Interventional Study with Duodenal–Jejunal Exclusion

(2009) Bruno Geloneze et al.   OBESITY SURGERY

Islet Inflammation in Type 2 Diabetes: From metabolic stress to therapy

(2008) M. Y. Donath et al.   DIABETES CARE

Effect of Weight Loss by Gastric Bypass SurgeryVersusHypocaloric Diet on Glucose and Incretin Levels in Patients with Type 2 Diabetes

(2008) Blandine Laferrère et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulates Transepithelial Glucose Transport

(2008) Satish K. Singh et al.   Obesity

Hyperbolic Relationship Between Insulin Secretion and Sensitivity on Oral Glucose Tolerance Test

(2008) Ravi Retnakaran et al.   Obesity

Laparoscopic Duodenal–Jejunal Exclusion in the Treatment of Type 2 Diabetes Mellitus in Patients with BMI < 30 kg/m2 (LBMI)

(2008) Almino C. Ramos et al.   OBESITY SURGERY

GLP-1 and Adiponectin: Effect of Weight Loss After Dietary Restriction and Gastric Bypass in Morbidly Obese Patients with Normal and Abnormal Glucose Metabolism

(2008) Camila Puzzi de Carvalho et al.   OBESITY SURGERY